Literature DB >> 34614404

Happy gut, happy kidneys? Restoration of gut microbiome ameliorates acute and chronic kidney disease.

Samuel Mon-Wei Yu1, John Cijiang He2.   

Abstract

In a new study, Zhu et al. (2021) show that mitigating dysbiosis by the probiotic L. casei Zhang reduces kidney inflammation via restoring short-chain fatty acid-producing gut microbiome and nicotinamide metabolism. These findings shed light on the underlying mechanisms of probiotics in treating human kidney diseases. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34614404      PMCID: PMC8994854          DOI: 10.1016/j.cmet.2021.08.019

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  10 in total

Review 1.  Probiotics and chronic kidney disease.

Authors:  Laetitia Koppe; Denise Mafra; Denis Fouque
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

2.  Probiotics and CKD Progression: Are Creatinine-Based Estimates of GFR Applicable?

Authors:  Kenneth D Lempert
Journal:  Am J Kidney Dis       Date:  2019-03-22       Impact factor: 8.860

3.  CSF-1 signaling mediates recovery from acute kidney injury.

Authors:  Ming-Zhi Zhang; Bing Yao; Shilin Yang; Li Jiang; Suwan Wang; Xiaofeng Fan; Huiyong Yin; Karlton Wong; Tomoki Miyazawa; Jianchun Chen; Ingrid Chang; Amar Singh; Raymond C Harris
Journal:  J Clin Invest       Date:  2012-11-12       Impact factor: 14.808

Review 4.  Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury.

Authors:  Jing Gong; Sanjeev Noel; Jennifer L Pluznick; Abdel Rahim A Hamad; Hamid Rabb
Journal:  Semin Nephrol       Date:  2019-01       Impact factor: 5.299

Review 5.  Acute Kidney Injury.

Authors:  Anna Zuk; Joseph V Bonventre
Journal:  Annu Rev Med       Date:  2016       Impact factor: 13.739

Review 6.  Immunity, microbiota and kidney disease.

Authors:  Felix Knauf; J Richard Brewer; Richard A Flavell
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

7.  PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection.

Authors:  Mei T Tran; Zsuzsanna K Zsengeller; Anders H Berg; Eliyahu V Khankin; Manoj K Bhasin; Wondong Kim; Clary B Clish; Isaac E Stillman; S Ananth Karumanchi; Eugene P Rhee; Samir M Parikh
Journal:  Nature       Date:  2016-03-16       Impact factor: 49.962

8.  Processed foods drive intestinal barrier permeability and microvascular diseases.

Authors:  Matthew Snelson; Sih Min Tan; Rachel E Clarke; Cassandra de Pasquale; Vicki Thallas-Bonke; Tuong-Vi Nguyen; Sally A Penfold; Brooke E Harcourt; Karly C Sourris; Runa S Lindblom; Mark Ziemann; David Steer; Assam El-Osta; Michael J Davies; Leigh Donnellan; Permal Deo; Nicole J Kellow; Mark E Cooper; Trent M Woodruff; Charles R Mackay; Josephine M Forbes; Melinda T Coughlan
Journal:  Sci Adv       Date:  2021-03-31       Impact factor: 14.136

9.  Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI.

Authors:  Petra Simic; Xavier Fernando Vela Parada; Samir M Parikh; Ryan Dellinger; Leonard P Guarente; Eugene P Rhee
Journal:  BMC Nephrol       Date:  2020-08-13       Impact factor: 2.388

10.  The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease.

Authors:  Han Zhu; Chujin Cao; Zhongcai Wu; Heping Zhang; Zhihong Sun; Meng Wang; Huzi Xu; Zhi Zhao; Yuxi Wang; Guangchang Pei; Qian Yang; Fengming Zhu; Juan Yang; Xuan Deng; Yu Hong; Yinzheng Li; Jie Sun; Fan Zhu; Mengxia Shi; Kun Qian; Ting Ye; Xuezhi Zuo; Fenfei Zhao; Jing Guo; Gang Xu; Ying Yao; Rui Zeng
Journal:  Cell Metab       Date:  2021-07-15       Impact factor: 27.287

  10 in total
  3 in total

Review 1.  Faecal Microbiota Transplantation and Chronic Kidney Disease.

Authors:  Ji Bian; Ann Liebert; Brian Bicknell; Xin-Ming Chen; Chunling Huang; Carol A Pollock
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 2.  Integrating the Synergy of the Gut Microbiome into Regenerative Medicine: Relevance to Neurological Disorders.

Authors:  Senthilkumar Preethy; Natarajan Ranganathan; Kadalraja Raghavan; Vidyasagar Devaprasad Dedeepiya; Nobunao Ikewaki; Samuel J K Abraham
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 3.  Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease.

Authors:  Ji Bian; Ann Liebert; Brian Bicknell; Xin-Ming Chen; Chunling Huang; Carol A Pollock
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.